Insufficient scRNA-seq data for expression of NPY4R at single-cell level.
Insufficient scRNA-seq data for expression of NPY4R at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 66% | 12.14 | 162 / 245 | 52% | 2.70 | 259 / 502 |
| intestine | 95% | 54.65 | 915 / 966 | 15% | 0.32 | 81 / 527 |
| stomach | 67% | 10.04 | 241 / 359 | 17% | 0.45 | 48 / 286 |
| skin | 71% | 18.61 | 1293 / 1809 | 0% | 0.00 | 1 / 472 |
| lung | 63% | 8.49 | 365 / 578 | 6% | 0.17 | 72 / 1155 |
| adipose | 47% | 6.93 | 560 / 1204 | 0% | 0 | 0 / 0 |
| breast | 44% | 5.41 | 200 / 459 | 1% | 0.01 | 9 / 1118 |
| esophagus | 16% | 1.05 | 231 / 1445 | 11% | 0.51 | 21 / 183 |
| brain | 18% | 1.76 | 479 / 2642 | 0% | 0 | 0 / 705 |
| ovary | 17% | 0.99 | 30 / 180 | 0% | 0.00 | 1 / 430 |
| thymus | 15% | 0.83 | 101 / 653 | 1% | 0.01 | 4 / 605 |
| bladder | 10% | 0.76 | 2 / 21 | 4% | 0.08 | 19 / 504 |
| pancreas | 7% | 0.37 | 22 / 328 | 6% | 0.19 | 11 / 178 |
| adrenal gland | 10% | 0.47 | 25 / 258 | 3% | 0.12 | 7 / 230 |
| heart | 8% | 0.50 | 67 / 861 | 0% | 0 | 0 / 0 |
| liver | 5% | 0.33 | 12 / 226 | 2% | 0.04 | 7 / 406 |
| uterus | 5% | 0.26 | 8 / 170 | 2% | 0.04 | 9 / 459 |
| spleen | 6% | 0.28 | 15 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 0.23 | 57 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 1% | 0.07 | 12 / 803 | 0% | 0 | 0 / 0 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.03 | 11 / 901 |
| peripheral blood | 0% | 0.02 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0007218 | Biological process | neuropeptide signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043005 | Cellular component | neuron projection |
| GO_0016020 | Cellular component | membrane |
| GO_0042923 | Molecular function | neuropeptide binding |
| GO_0017046 | Molecular function | peptide hormone binding |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0001602 | Molecular function | pancreatic polypeptide receptor activity |
| Gene name | NPY4R |
| Protein name | Neuropeptide Y receptor type 4 (NPY4-R) (Pancreatic polypeptide receptor 1) (PP1) |
| Synonyms | PPYR1 |
| Description | FUNCTION: G protein-coupled receptor for PPY/pancreatic polypeptide/PP, NPY/neuropeptide Y and PYY/peptide YY that is negatively coupled to cAMP . The rank order of affinity for these polypeptides and their derivatives is PP, PP (2-36) and [Ile-31, Gln-34] PP > [Pro-34] PYY > PYY and [Leu-31, Pro-34] NPY > NPY > PYY (3-36) and NPY (2-36) > PP (13-36) > PP (31-36) > NPY free acid. . |
| Accessions | ENST00000374312.5 ENST00000612632.3 P50391 |